Intellia Therapeutics (NTLA) Net Margin Growth (1y) (2016 - 2026)
Intellia Therapeutics (NTLA) Net Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - | 25,623.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,623.00 |
| Dec 31, 2025 | 58,162.00 |
| Sep 30, 2025 | -3,441.00 |
| Jun 30, 2025 | 121,747.00 |
| Mar 31, 2025 | -108,744.00 |
| Dec 31, 2024 | -950,394.00 |
| Sep 30, 2024 | -26,027.00 |
| Jun 30, 2024 | -66,217.00 |
| Mar 31, 2024 | 81,834.00 |
| Dec 31, 2023 | 932,118.00 |
| Sep 30, 2023 | 34,369.00 |
| Jun 30, 2023 | 6,539.00 |
| Mar 31, 2023 | 183,375.00 |
| Dec 31, 2022 | -16,157.00 |
| Sep 30, 2022 | 768,715.00 |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 403,109.00 |
| Dec 31, 2021 | 213,752.00 |
| Sep 30, 2021 | -904,260.00 |
| Jun 30, 2021 | -1.54 Mn |